The prevalence and incidence of Systemic Lupus Erythematosus (SLE) in selected cities from three Commonwealth of Independent States countries (the Russian Federation, Ukraine and Kazakhstan)

Author:

Nasonov E1,Soloviev S1,Davidson JE2,Lila A3,Ivanova R4,Togizbayev G5,Omarbekova Z6,Shevchuk S7,Iaremenko O8,Gnylorybov A9,Smailova Z10,Chernogolov V11,Malynovska K12,Vasylyev A13,Pereira MHS13

Affiliation:

1. Institute of Rheumatology, Russian Academy of Medical Science, Russian Federation

2. Worldwide Epidemiology, GlaxoSmithKline R&D, UK

3. North-Western Medical University named after I.I. Mechnikov State Medical Academy of St. Petersburg, Russian Federation

4. Semey State Medical University, Internal Medicine Department, Kazakhstan

5. Institute of Joint Diseases, Rheumatology Department, Kazakhstan

6. Semey State Medical University, Medical Centre, Kazakhstan

7. Scientific Research institute of Rehabilitation of the Ministry of Health of Ukraine on the base of Pirogov National Medical University, Ukraine

8. National Medical University named after O.O. Bogomolets, Ukraine

9. Institute of Urgent and Recovery Surgery named after V.K. Gusak, National Academy of Medical Sciences of Ukraine, Ukraine

10. Kazakhstan Medical Department, GlaxoSmithKline, Kazakhstan

11. Russia Medical Department, GlaxoSmithKline, Russian Federation

12. Ukraine Medical Department, GlaxoSmithKline, Ukraine

13. Commonwealth of Independent States Medical Department, GlaxoSmithKline, UK

Abstract

We assessed the prevalence and incidence of Systemic Lupus Erythematosus (SLE) in 2010 in adults from four cities in Russia, Kazakhstan and Ukraine. Individuals with SLE were identified retrospectively from the medical records of specialized centers. Prevalent SLE patients were nondeceased city residents, diagnosed prior to December 31, 2010; incident patients were residents newly diagnosed between January 1 and December 31, 2010. Population size was obtained from official census data. The observed prevalence rates (per 100,000, 95% CI) were 9.0 (7.1–11.2) in Kursk and Yaroslavl, Russian Federation; 20.6 (15.4–27.0) in Semey, Kazakhstan; and 14.9 (10.9–19.9) in Vinnitsa, Ukraine. The cumulative incidence rates (per 100,000, 95% CI) were 1.4 (0.7–2.4); 1.6 (0.4–4.1) and 0.3 (0.0–1.8), correspondingly. All rates were higher among females compared to males, and incidence peaked in the population aged 25–44. These rates appear slightly lower than those reported from Western Europe and the USA. This could be because of study design (case-ascertainment), local health care practices or true differences in disease risk. Case age and sex distribution was similar to the known epidemiology of SLE. The rates were highest in Kazakhstan, likely because of a predominantly ethnic Asian population.

Publisher

SAGE Publications

Subject

Rheumatology

Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3